Related Experiment Video

Updated: Aug 29, 2026

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer
10:36

Systems Biology of Metabolic Regulation by Estrogen Receptor Signaling in Breast Cancer

Published on: March 17, 2016

Advances in estrogen receptor biology: prospects for improvements in targeted breast cancer therapy

Wenlin Shao1, Myles Brown

  • 1Division of Molecular and Cellular Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, and Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.

Breast Cancer Research : BCR
|December 19, 2003
PubMed

Insights

Estrogen receptor (ER) is key in breast cancer treatment response. Understanding ER pathways and resistance factors is vital for improving endocrine therapies for ER-positive breast cancers.

Area of Science:

  • Oncology
  • Endocrinology
  • Molecular Biology

Background:

  • Estrogen receptor (ER) plays a critical role in breast development and is a hallmark of common breast cancer subtypes.
  • ER expression is a strong predictor of response to endocrine therapy in ER-positive breast cancers.

Purpose of the Study:

  • To explore the role of estrogen receptor (ER) in breast cancer.
  • To identify factors influencing sensitivity and resistance to endocrine therapy.
  • To highlight emerging strategies for improving breast cancer treatment based on ER function.

Main Methods:

  • Review of current endocrine therapies targeting ER function.
  • Analysis of factors contributing to intrinsic and acquired resistance.
  • Exploration of the coordinated action of ER, coregulatory factors, and intracellular signaling cascades.

Main Results:

  • Endocrine therapies target estrogen levels, ER action, and ER degradation.
  • Therapeutic effectiveness is often limited by resistance mechanisms.
  • Understanding ER pathways and signaling is crucial for overcoming resistance.

Conclusions:

  • Improved understanding of ER's coordinated action with coregulatory factors and signaling pathways is essential.
  • This knowledge can lead to novel therapeutic strategies for ER-positive breast cancers.
  • Further research into sensitivity and resistance factors will enhance breast cancer treatment outcomes.

More Related Videos

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...